Tags

Dosing and absorption Tadalafil (Cialis)

Posted in August 11th, 2009
Published in Pharmacology

Recommended starting doses of tadalafil are 10 mg for on-demand dosing and 2.5 mg for once-daily dosing, and these doses can then be titrated up or down according to the efficacy and tolerability. It is absorbed as a low-solubility and high-permeability, or Class 2, drug within the FDA Biopharmaceuticals Classification System. With oral ingestion, after [...]

read more from " Dosing and absorption Tadalafil (Cialis) "

Phosphodiesterase selectivity

Posted in August 8th, 2009
Published in Pharmacology

Tadalafil is at least 9000 times more selective for PDE5 than most of the other families of PDEs, with the exception of PDE11. PDE11 is found in the testes and prostate; however, despite partial inhibition of PDE11 by tadalafil at therapeutic doses, clinical significance of this observation has yet to be fully understood. A study [...]

read more from " Phosphodiesterase selectivity "

History of the development of tadalafil

Posted in July 23rd, 2009
Published in Main

The Bothell, Washington-based pharmacologic research company ICOS Corporation was started in 1990, and it began the initial cardiovascular testing of a PDE5 inhibitor called IC351 in 1993. Meanwhile, sildenafil citrate (sildenafil) was discovered to cause improved erectile function as a side effect in a trial testing its efficacy for the treatment of angina pectoris in [...]

read more from " History of the development of tadalafil "